NEW YORK (GenomeWeb) – Diagnostics developer HealthTell announced today that it has completed a $26 million Series B financing round led by Third Point Ventures.

The company, which also raised $14 million in a previous Series A round, plans to use the proceeds to commercialize panels for tests for autoimmune diseases, such as lupus.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that researchers in Italy are testing a gene drive aimed at controlling mosquito populations.

Researchers may experience the effects of the government shutdown for a while, the Los Angeles Times reports.

A new study finds that the majority of patients at a Tijuana clinic received a diagnosis after first-line genome sequencing, the San Diego Union-Tribune reports.

In Genome Biology this week: post-transcriptional modification-based stratification of glioblastoma, single-cell analysis of gene expression and methylation in human iPSCs, and more.